ESPERION THERAPEUTICS, INC.

Company

Esperion Therapeutics, Inc.

Filed

April 5, 2023

Accession Number

0000902664-23-002476

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →